Lung cancer is the neoplastic disease with the highest mortality numbers in the world. The disease is very common in industrialized countries. Written with the practicing clinician in mind, this textbook offers numerous invaluable insights. Clinical evidence is summarized in the following fields: epidemiology, biology, pathology, diagnosis, treatment, and prognosis.
Summarizes the clinician's approach to lung cancer
International and multidisciplinary editorship
Evidence-based conclusions summarize each chapter
Rezensionen / Stimmen
From the reviews:"Lung cancer is a global epidemic .. Malignant Tumors of the Lung comes at a time when there are more options and perhaps less nihilism in the treatment of this disease. . The high points of the book are the illustrations, tables and charts. This is essential reading for medical professionals involved in the care of patients with lung cancer." (Nithya Ramnath, Oncology, Vol. 67 (56), 2004)
Auflage
Sprache
Verlagsort
Zielgruppe
Für Beruf und Forschung
Für höhere Schule und Studium
Professional/practitioner
Illustrationen
75
75 s/w Tabellen
26 black & white illustrations, 25 colour illustrations, 75 black & white tables
Maße
Höhe: 24.2 cm
Breite: 19.3 cm
Dicke: 19 mm
Gewicht
ISBN-13
978-3-540-43887-8 (9783540438878)
DOI
10.1007/978-3-642-18698-1
Schweitzer Klassifikation
Epidemiology, biology and pathology: Molecular and cell biology. Useful biomarkers. Pathology. Incidence and epidemiological data. Smoking and tobacco control. Professional risks and environment factors.- Early detection, diagnosis and staging: Radiological screening. Endoscopy detection. Clinical presentation and paraneoplastic syndromes. Differential diagnosis. Imaging (RX, CT, MRI, US). PET scan. Pathological diagnosis obtention. Mediastinal staging. Operability assessment. TNM staging.- Treatment: Non small cell lung cancer. Surgery. Neoadjuvant treatments. Adjuvant treatments. Elective radiotherapy. Chemotherapy. Salvage therapy. Small cell lung carcinoma. Limited disease. Extensive disease. Preventive cranial irradiation. Salvage therapy. Chemoprevention. Endoscopic treatments. Biological treatments.- Complications and supportive care: BM aplasia. SVCS. Airway obstruction. Malignant pleural effusion. Symptomatic treatment. Palliative care.- Prognosis: NSCLC prognosis. SCLC prognosis.
